Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

BUY
$1.92 - $6.28 $38,814 - $126,956
20,216 New
20,216 $56,000
Q1 2022

May 16, 2022

SELL
$5.07 - $7.2 $231,349 - $328,543
-45,631 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$5.67 - $8.54 $258,727 - $389,688
45,631 New
45,631 $293,000
Q3 2021

Nov 15, 2021

SELL
$13.4 - $16.3 $148,485 - $180,620
-11,081 Closed
0 $0
Q2 2021

Aug 13, 2021

SELL
$14.81 - $19.13 $19,756 - $25,519
-1,334 Reduced 10.75%
11,081 $164,000
Q1 2021

May 14, 2021

BUY
$14.52 - $23.53 $180,265 - $292,124
12,415 New
12,415 $221,000
Q1 2018

May 14, 2018

SELL
$9.0 - $20.16 $115,254 - $258,168
-12,806 Closed
0 $0
Q4 2017

Feb 09, 2018

BUY
$13.26 - $22.86 $169,807 - $292,745
12,806
12,806 $249,000

Others Institutions Holding OMER

About OMEROS CORP


  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $620M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track Dynamic Technology Lab Private LTD Portfolio

Follow Dynamic Technology Lab Private LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.